ALEXANDRA BALBIR-GURMAN

Objective:Outcome of COVID-19 patients improved over the pandemic, i ncludi ngpatients with systemic rheumatic diseases. However, data on systemic sclerosis (SSc)patients are lacking. Th is study aimed to assess the outcome of SSc patients withCOV ID-19 over several waves. Methods:SSc patients with COVID-19 registered in...

Objective: Data on the role of tobacco exposure in systemic sclerosis (SSc; scleroderma) severity and progression are scarce. We aimed to assess the effects of smoking on the evolution of pulmonary and skin manifestations, based on the European Scleroderma Trials and Research group database. Methods: Adult SSc patients with data on smoking...